保龄宝：取得乳果糖原料药药品生产许可证

Core Viewpoint - The company, Baolingbao (002286), has recently obtained a "Drug Production License" from the Shandong Provincial Drug Administration, which allows it to produce the raw material drug lactulose solution, marking the beginning of its diversification into raw material drugs [1] Group 1 - The acquisition of the "Drug Production License" accelerates the subsequent application, registration, and market launch processes for the company's first raw material drug, lactulose [1] - This license represents a significant step in the company's strategy to diversify its raw material drug offerings [1]